XQ, T., XW, N., HL, X., L, Z., DL, Z., B, C., . . . YZ, Z. (2017). Prevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destruction. Dove Medical Press.
Cita Chicago Style (17a ed.)XQ, Tian, Ni XW, Xu HL, Zheng L, ZhuGe DL, Chen B, Lu CT, Yuan JJ, y Zhao YZ. Prevention of Doxorubicin-induced Cardiomyopathy Using Targeted MaFGF Mediated by Nanoparticles Combined with Ultrasound-targeted MB Destruction. Dove Medical Press, 2017.
Cita MLA (8a ed.)XQ, Tian, et al. Prevention of Doxorubicin-induced Cardiomyopathy Using Targeted MaFGF Mediated by Nanoparticles Combined with Ultrasound-targeted MB Destruction. Dove Medical Press, 2017.
Precaución: Estas citas no son 100% exactas.